TSG Capital
Funding rounds backed by TSG Capital.
- Funding disclosed in full
- $150M
- Median round
- $150M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Full-Life Technologies Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150MSeries D+Debt | BiotechChina |